RIVANNA's New Patent: A Leap in Ultrasound-Guided Systems
RIVANNA Secures Innovative Patent for Needle Insertion Tech
RIVANNA, a pioneering company in imaging-based medical solutions, has recently made an exciting advancement in medical technology. The company announced the acquisition of a new patent for an advanced ultrasound-guided needle insertion system, designed to greatly improve the accuracy and safety of various needle-based medical procedures.
Introducing the Advanced Ultrasound-Guided System
This groundbreaking system, identified by US Patent #11,432,801 B2, showcases cutting-edge ultrasound-guided needle insertion technology. Its primary aim is to bolster the feasibility, accuracy, and safety of precise needle insertions into various anatomical structures such as organs, tumors, and blood vessels. These enhancements are critical for multiple procedures, including targeted biopsies, therapeutic injections, fluid aspirations, and catheter placements.
Innovative Design Features
The patented system features a unique dual-array multi-angle probe. This innovative design enables ultrasound arrays to transmit and receive angled sound waves, improving visibility of needle paths within the patient’s anatomy. Furthermore, a detachable needle guide ensures proper alignment and enhances real-time visualization—key factors for ensuring accurate and reliable needle insertions.
Tackling Challenges in Current Medical Practices
RIVANNA is addressing notable challenges in traditional medical procedures. As highlighted by the company’s co-founder and CEO, Dr. Will Mauldin, ultrasound-guided procedures have historically demanded sophisticated techniques and multiple operators due to technical constraints. For instance, the need for three hands to manage the needle, probe, and syringe often complicates procedures. Additionally, steep needle angles can hinder the effective visualization required during interventions.
Enhancing Patient Safety and Outcomes
The advanced technology devised by RIVANNA confidently overcomes these obstacles, thereby facilitating broader implementation of ultrasound guidance. This ensures improved safety and accuracy in procedures, ultimately leading to better patient outcomes.
Collaboration for Improvement
The importance of collaboration in achieving this innovation cannot be overstated. RIVANNA acknowledges the vital contributions of Dr. Charles Y. Kim from Duke University, whose foundational research in ultrasound-guided interventions played a pivotal role in the development of the patented technology. This collaboration exemplifies the productive partnership between academic research and industry innovation that drives progress in medical technology.
Integration into RIVANNA's Product Line
Under the guidance of Dr. Adam Dixon, RIVANNA's Executive VP of Engineering, the company is now working on integrating this patented technology into its existing product range. As they progress, RIVANNA plans to announce details regarding the commercial availability of this pioneering system.
About RIVANNA
RIVANNA is a leading innovator and manufacturer of medical devices, focused on enhancing healthcare through its pioneering imaging technologies. The company's mission revolves around delivering world-first, imaging-based medical solutions that significantly improve global healthcare standards. Their portfolio includes comprehensive imaging options for spinal needle interventions and diagnosis, all designed with precision and safety in mind. RIVANNA emphasizes cost-effective solutions without compromising quality. By offering advanced ultrasound-based imaging platforms with artificial intelligence-driven guidance, RIVANNA provides a significant boost to modern medical practices. As a privately held entity, RIVANNA operates out of an FDA-registered and ISO 13485:2016-certified facility.
Frequently Asked Questions
What is the purpose of RIVANNA's new technology?
RIVANNA's new ultrasound-guided needle insertion system aims to enhance the accuracy and safety of needle-based procedures, such as biopsies and catheter placements.
Who contributed to the development of this new technology?
Dr. Charles Y. Kim from Duke University significantly contributed to the foundational research that enabled the development of this innovative system.
How does this technology improve safety during procedures?
The patented system uses advanced ultrasound visualization to ensure that needles are inserted correctly, which reduces the likelihood of complications and improves patient outcomes.
What types of procedures can benefit from RIVANNA's system?
The technology is applicable for a variety of interventions, including targeted biopsies, injections, and catheter placements.
Is RIVANNA focused only on ultrasound technology?
No, RIVANNA is dedicated to developing a range of imaging-based medical technologies that elevate healthcare standards, which includes various diagnostic and intervention solutions.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Concord Medical Financial Update: First Half of 2024 Insights
- Discover the Pre-registration for Bybit's Physical Card
- Top Semiconductor Stocks to Watch Amid AI Demand Growth
- Examining Super Micro's Challenges Amid Regulatory Scrutiny
- The Expanding Nitrile Gloves Market and Its Growth Potential
- Welshare Health's New AI App Revolutionizes Patient Research
- Septerna Initiates Promising Clinical Trial for SEP-786
- Calian Group Partners with Microsoft for Cloud Cybersecurity Solutions
- Covalon Technologies to Showcase Innovations in Vascular Access Care
- Flow Beverage Corp. Set for Key Investor Conference Engagement
Recent Articles
- Inland Empire Health Plan Achieves National Recognition in Procurement
- Jen Brull, MD, FAAFP, Takes Leadership Role at AAFP
- Ironclad Achieves Leadership Recognition in Contract Management
- Archer Aviation's Journey Through Market Turbulence and Growth
- Lottery.com Expands Sports.com with Strategic CMF Media Acquisition
- Mizuho Maintains Neutral Rating for IDACORP Amid Growth Insights
- Cibus Global Experiences Significant Stock Decline and Changes
- 908 Devices Faces Market Low with Promising Future Growth Prospects
- Qwest Corp ELKS (CTBB) Shares Hit New High Amid Strong Growth
- Silver Wheaton Corp Reaches New Heights in Stock Performance
- Pakistan Secures $7 Billion Loan Approval from IMF Board
- Micron: Anticipating Earnings and Growth in Semiconductor Sector
- Ken Fisher's Warning: The Risks of Prioritizing Capital Preservation
- Explore the Ultimate Fall Guide from Diamond Certified Resource
- Splashtop Strengthens Security Collaboration with MISA Membership
- Exploiting Opportunities in Goldman Sachs Options Trading
- Monthly Distribution Announcement for High Income Securities Fund
- BlackRock TCP Capital Corp. Gets Credit Ratings Boost
- Exploring Lamb Weston Hldgs: A Deep Dive into Stock Trends
- Understanding Recent Unusual Options Activity for Marvell Tech
- Freenome Begins New Leadership Era with CEO Transition
- Combat Waffle Studios Celebrates Over $20M in VR Game Revenue
- Urgent Call for Action to Prevent Port Closures Impacting Agri
- Exploring Hotel Safety Concerns: Legal Insights and Actions
- Vir Biotechnology's Journey: Challenges and New Innovations
- Harmonizing Agriculture with Technology: A New Path Forward
- Mizuho Adjusts Brookfield Renewable Price Target to $27
- GoDaddy's Gross Margin: Insights from Barclays Review
- Global Payments' Transformation: Analyst Forecasts Positive Outlook
- Goldman Sachs Maintains Buy Rating on Disney Amid Challenges
- Goldman Sachs Highlights Key Concerns for Worthington Industries
- Hennessy Capital Investment Corp. V Reaches New Heights
- Editas Medicine's Stock Challenges Highlight Market Pressures
- Zhong Yang Financial's Stock Falls to Troubling New Lows
- Investors Weigh Bitcoin's Value Against Gold and Oil
- The Entrepreneurial Leap: How Lubetzky Scaled KIND Snacks
- Exploring the Future Growth of the Global Absorbent Mats Market
- SYNERGIE Sees Growth Amid Market Challenges with Financial Strength
- Bassett Furniture Schedules Conference Call for Q3 Insights
- Bassett Furniture Industries to Host Q3 2024 Conference Call
- Transforming Startup Success: Nashville Entrepreneur Center's New Programs
- Lottery.com Expands Sports Entertainment Portfolio with CMF Media
- Factors Influencing Bitcoin's Potential Price Surge Ahead
- Lottery.com Expands with Acquisition of CMF Media for Sports Entertainment
- Alegria™ Introduces Stylish Fall Boots and Mary Janes
- Important Notice for Domino's Pizza, Inc. Investors Ahead of Legal Deadline
- Canva Developer Platform Surges as App Usage Breaks 1 Billion
- Understanding the Role of Agency REITs in Economic Growth
- ECL Unveils Groundbreaking 1GW Off-Grid AI Factory Data Center
- Recent Surge in Amazon.com Options Activity Signals Bullish Trends